Abstract:Background: Patients with COPD are at high risk of lung cancer developing, but no validated predictive biomarkers have been reported to identify these patients. Molecular profiling of exhaled breath by electronic nose (eNose) technology may qualify for early detection of lung cancer in patients with COPD. Research question: Can eNose technology be used for prospective detection of early lung cancer in patients with COPD? Study design and methods: BreathCloud is a real-world multicenter prospective follow-up study using diagnostic and monitoring visits in day-to-day clinical care of patients with a standardized diagnosis of asthma, COPD, or lung cancer. Breath profiles were collected at inclusion in duplicate by a metal-oxide semiconductor eNose positioned at the rear end of a pneumotachograph (SpiroNose; Breathomix). All patients with COPD were managed according to standard clinical care, and the incidence of clinically diagnosed lung cancer was prospectively monitored for 2 years. Data analysis involved advanced signal processing, ambient air correction, and statistics based on principal component (PC) analysis, linear discriminant analysis, and receiver operating characteristic analysis. Results: Exhaled breath data from 682 patients with COPD and 211 patients with lung cancer were available. Thirty-seven patients with COPD (5.4%) demonstrated clinically manifest lung cancer within 2 years after inclusion. Principal components 1, 2, and 3 were significantly different between patients with COPD and those with lung cancer in both training and validation sets with areas under the receiver operating characteristic curve of 0.89 (95% CI, 0.83-0.95) and 0.86 (95% CI, 0.81-0.89). The same three PCs showed significant differences (P < .01) at baseline between patients with COPD who did and did not subsequently demonstrate lung cancer within 2 years, with a cross-validation value of 87% and an area under the receiver operating characteristic curve of 0.90 (95% CI, 0.84-0.95). Interpretation: Exhaled breath analysis by eNose identified patients with COPD in whom lung cancer became clinically manifest within 2 years after inclusion. These results show that eNose assessment may detect early stages of lung cancer in patients with COPD.

Detection of lung cancer and stages via breath analysis using a self-made electronic nose device

Development Of Electronic Nose For Diagnosis Of Lung Cancer At Early Stage

Research on Hybrid Recognition Algorithms of Lung Cancer Breath Diagnosis Based on MOS and SAW Sensors

Electronic Nose for Detecting Lung Cancer Based on Virtual Gas Sensor Array

A Portable Electronic Nose Intended for Home Healthcare Based on a Mixed Sensor Array and Multiple Desorption Methods

Low-Cost Lung Cancer Detection Using Machine Learning on Breath Samples

Nose-on-Chip Nanobiosensors for Early Detection of Lung Cancer Breath Biomarkers

MOS Sensors Array for the Discrimination of Lung Cancer and At-Risk Subjects with Exhaled Breath Analysis

How well does your E-nose detect cancer? Application of artificial breath analysis for performance assessment

Artificial Intelligence Based Breath Analysis System for the Diagnosis of lung cancer

Recognizing lung cancer and stages using a self-developed electronic nose system

Prediction of lung cancer with a sensor array based e-nose system using machine learning methods

Breath Analysis for Detecting Diseases on Respiratory, Metabolic and Digestive System

Online breath analysis using metal oxide semiconductor sensors (electronic nose) for diagnosis of lung cancer

Breathomics: may it become an affordable, new tool for early diagnosis of non-small-cell lung cancer? An exploratory study on a cohort of 60 patients

Prediction of Pulmonary Diseases With Electronic Nose Using SVM and XGBoost

The potential of electronic nose technology in lung transplantation: a proof of principle

A review on electronic nose for diagnosis and monitoring treatment response in lung cancer

The Accuracy of Breath Analysis for Lung Cancer Detection Using a Portable Colorimetric Sensor Array System

Exhaled breath analysis by electronic nose in respiratory diseases

Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath